This record was last updated September 10, 2025 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.
Summary
This is study to determine the visual performance of patients with age-related cataracts implanted in both eyes with either of two extended depth of focus intraocular lenses, the Clareon Vivity (Alcon Healthcare) or the PureSee (Johnson \& Johnson)